Iron deposition in the kidney worsens the progression of lupus nephritis (LN), leading to increased disease activity of SLE, while reducing the renal accumulation by iron chelator or hepcidin in the kidney improves the progression of LN in mice (12, 13), suggesting that altering iron homeostasis may be a promising therapeutic method for SLE. Here, HAMP is linked to lobular neoplasia.